Amid a surge in healthcare deals globally last year including those backed by private equity, Asia Pacific’s disclosed deal value surged to $7.2 billion, with 61 deals in 2017 as compared to 52 in 2016, the highest level since 2001 and the momentum is expected to continue this year, a report from Bain & Company has said.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
